![Immunotherapy treatment with ipilumimab for high-risk melanoma](https://www.hoaapharmacy.com/wp-content/uploads/2016/11/Ipilimumab-news-for-HOAA.jpg)
Immunotherapy treatment with ipilumimab after resection of high-risk melanoma improves overall survival compared to no treatment. In high risk melanoma lesions where a cutaneous melanoma has spread to local lymph nodes, despite surgical resection, only about 45% of patients will not have the melanoma come back within 4 years. Currently, there are no great medical… Read more »